Mineral-Homeostasis in Continuous Renal Replacement Therapy
NCT ID: NCT01946113
Last Updated: 2015-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2013-09-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. record retrospectively how often abnormal values for phosphate, magnesium and calcium occurred during routine renal replacement therapy in 2011 and 2012.
2. prospectively evaluate the same parameters during routine treatment in 2013 and 2014
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients
NCT01700998
Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.
NCT02194569
Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
NCT06472999
Analysis of Clinical Outcomes in Patients Undergoing Acute Dialysis Therapy at Intensive Care Units
NCT01039753
Investigating Different Anticoagulants for Renal Replacement Therapy
NCT02669589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospektive Cohort
Patients requiring renal replacement therapy from 2011 to 2012 on intensive care unit
No interventions assigned to this group
Prospektive Cohort
Patients requiring renal replacement on intensive care unit in 2013 and 2014
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* older than 18 years of age
Exclusion Criteria
* pregnancy
* contraindications against continuous renal replacement therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Anästhesiologie
Prof. Kindgen-Milles
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Detlef Kindgen-Milles, Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesiology, Duesseldorf University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Interdisziplinäre Intensivstation Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4209
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.